From: Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
Continent | Country | Mean CIMP-H prevalence | 95% CI | Smoking % | Alcohol drinkers % | Obesity% |
---|---|---|---|---|---|---|
Africa | Tunisia | 32% | 23–42% | 40.93% | 20% | 27% |
Australia | Australia | 20% | 13–27% | 14.8% | 11.9% | 29% |
New Zealand | 35% | 26–45% | 14.9% | 12% | 31% | |
Asia | China | 24% | 12–35% | 25.2% | 10.6% | 6% |
India | 44% | 37–51% | 11.3% | 22.3% | 4% | |
Japan | 26% | 20–32% | 22.5% | 9.90% | 4% | |
Taiwan | 16% | 12–20% | 18% | NA | NA | |
South Korea | 21% | 11–31% | 23.6 | 19.90% | 7% | |
Kuwait | 9% | 5–16% | 19.9% | 3.10% | 38% | |
Saudi Arabia | 6% | 3–10% | 13.6% | NA | 35% | |
Europe | Greece | 10% | 6–15% | 43.7% | 15% | 25% |
Italy | 21% | 14–28% | 23.8% | 13% | 20% | |
Spain | 24% | 18–31% | 29.4% | 21% | 24% | |
France | 17% | 15–19% | 32.9% | 14.90% | 22% | |
Switzerland | 9% | 6–12% | 25.8% | 13.40% | 20% | |
United Kingdom | 12% | 1–24% | 22.4% | 15.60% | 28% | |
Netherlands | 34% | 21–48% | 25.9% | 13.90% | 20% | |
Norway | 19% | 17–21% | 20.2% | 8.70% | 23% | |
Sweden | 13% | 11–15% | 18.9% | 12.50% | 21% | |
Denmark | 38% | 35–42% | 19.1% | 14.40% | 20% | |
Germany | 16% | 12–20% | 30.7% | 13.40% | 22% | |
Poland | 25% | 19–31% | 28.2% | 17.90% | 23% | |
Czech Republic | 50% | 42–59% | 34.4% | 19.50% | 26% | |
Ireland | 43% | 29–58% | 24.4% | 19.30% | 25% | |
North America | United States | 27% | 23–31% | 21.9% | 14.40% | 36% |
South America | Brazil | 25% | 18–31% | 14% | 18.50% | 22% |